• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Matthew Perrone

Stay informed with Matthew Perrone’s coverage and analysis.

Elf Bar and other Chinese e-cigarette makers dodged U.S. customs and taxes by labeling them as ‘battery chargers,’ ‘flashlights’ and other items
Finance
Elf Bar and other Chinese e-cigarette makers dodged U.S. customs and taxes by labeling them as ‘battery chargers,’ ‘flashlights’ and other items
By Matthew Perrone and The Associated PressDecember 19, 2023
A colorful assortment of disposable e-cigarettes
Retail
U.S. lawmakers tried banning Elf Bar and other e-cigarettes imported from China—it didn’t work, and now they’re trying again
By Matthew Perrone and The Associated PressDecember 8, 2023
packs of menthol cigarettes sits on a table
Health
Menthol cigarette ban delay raises anti-smoking group fears that the proposal may fall apart
By Matthew Perrone and The Associated PressDecember 7, 2023
Doctors are prescribing the trendy, mind-altering drug ketamine for hard-to-treat pain. Experts worry the U.S. may be repeating mistakes that gave rise to the opioid crisis
Health
Doctors are prescribing the trendy, mind-altering drug ketamine for hard-to-treat pain. Experts worry the U.S. may be repeating mistakes that gave rise to the opioid crisis
By Matthew Perrone and The Associated PressNovember 6, 2023
Vaping
Health
The teens are vaping less, as high school student ecigarette use plunges to 10% in nationwide CDC study
By Mike Stobbe, Matthew Perrone and The Associated PressNovember 2, 2023
Two teenagers vaping
Environment
E-cigarettes pose a new environmental dilemma—the ‘insidious devices’ can be neither recycled nor thrown in the trash
By Matthew Perrone and The Associated PressOctober 19, 2023
A hand holding an Elf Bar disposable vaping pod device.
Health
Chinese vaping company bypasses FDA ban with simple name change
By Matthew Perrone and The Associated PressOctober 13, 2023
FDA takes aim at ‘unsafe or ineffective’ laboratory medical tests, warns of ‘false or misleading claims’ amid regulatory ambiguity
Health
FDA takes aim at ‘unsafe or ineffective’ laboratory medical tests, warns of ‘false or misleading claims’ amid regulatory ambiguity
By Matthew Perrone and The Associated PressSeptember 29, 2023
An experimental treatment for ALS will get its day before the FDA this week—but the agency is unconvinced it works
Health
An experimental treatment for ALS will get its day before the FDA this week—but the agency is unconvinced it works
By Matthew Perrone and The Associated PressSeptember 25, 2023
Sudafed
Health
The top decongestant on the market doesn’t actually decongest, FDA says
By Matthew Perrone and The Associated PressSeptember 12, 2023
First U.S. over-the-counter birth control pill gets FDA approval and will be available early next year
Health
First U.S. over-the-counter birth control pill gets FDA approval and will be available early next year
By Matthew Perrone and The Associated PressJuly 13, 2023
Leqembi
Health
First Alzheimer’s drug shown to modestly slow cognitive decline gets full FDA approval
By Matthew Perrone and The Associated PressJuly 6, 2023
FDA slams the most popular disposable e-cigarette in U.S. as ‘addicting our nation’s youth’ and warns stores to stop selling it
Health
FDA slams the most popular disposable e-cigarette in U.S. as ‘addicting our nation’s youth’ and warns stores to stop selling it
By Matthew Perrone and The Associated PressJune 22, 2023
More gay men can donate blood after controversial decades-old rules to protect from HIV infections are loosened
Health
More gay men can donate blood after controversial decades-old rules to protect from HIV infections are loosened
By Matthew Perrone and The Associated PressMay 11, 2023
An FDA panel just voted unanimously in favor of over-the-counter birth control paving the way for nationwide access
Health
An FDA panel just voted unanimously in favor of over-the-counter birth control paving the way for nationwide access
By Matthew Perrone and The Associated PressMay 10, 2023
1
  • 2
  • 3
  • 4
  • 5
  • 6
...8
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.